Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants
- PMID: 31534211
- DOI: 10.1038/s41436-019-0655-2
Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants
Erratum in
-
Correction: Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy-number variants.Genet Med. 2020 Mar;22(3):670-671. doi: 10.1038/s41436-019-0725-5. Genet Med. 2020. PMID: 31844178
Abstract
Purpose: The ability of a single technology, next-generation sequencing, to provide both sequence and copy number variant (CNV) results has driven the merger of clinical cytogenetics and molecular genetics. Consequently, the distinction between the definition of a sequence variant and a CNV is blurry. As the 2015 American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) standards and guidelines for interpretation of sequence variants address CNV classification only sparingly, this study focused on adapting ACMG/AMP criteria for single-gene CNV interpretation.
Methods: CNV-specific modifications of the 2015 ACMG/AMP criteria were developed and their utility was independently tested by three diagnostic laboratories. Each laboratory team interpreted the same 12 single-gene CNVs using three systems: (1) without ACMG/AMP guidance, (2) with ACMG/AMP criteria, and (3) with new modifications. A replication study of 12 different CNVs validated the modified criteria.
Results: The adapted criteria system presented here showed improved concordance and usability for single-gene CNVs compared with using the ACMG/AMP interpretation guidelines focused on sequence variants.
Conclusion: These single-gene CNV criteria modifications could be used as a supplement to the ACMG/AMP guidelines for sequence variants, allowing for a streamlined workflow and a step toward a uniform classification system for both sequence and copy number alterations.
Keywords: ACMG/AMP criteria; PVS1; copy number variant (CNV); variant classification guidelines; variant interpretation.
References
-
- Lindy As, Stosser MB, Butler E, et al. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders. Epilepsia. 2018;59:1062–1071. - DOI
-
- Truty R, Paul J, Kennemer M, et al. Prevalence and properties of intragenic copy number variation in Mendelian disease genes. Genet Med. 2018;21:114–123. - DOI
-
- American Board of Medical Genetics and Genomics. Training Options. http://www.abmgg.org/pages/training_options.shtml . Accessed 10 April 2019.
-
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. - DOI
-
- Firth HV, Richards SM, Bevan AP, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Am J Hum Genet. 2009;84:524–533. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
